The FTC on Thursday approved pharmaceutical company Abbott Laboratories' (ABT) - Get Free Report bid to purchase Alere (ALR) - Get Free Report , a manufacturer of rapid point-of-care diagnostic tests, on the condition that Abbott sells two point-of-care medical testing units.
Shares of Abbott Laboratories were spiking over 3%, while shares of Alere were higher over 3.5% in afternoon trading on Thursday.
The deal, first proposed in February 2016, hit several snags on its route to approval over issues regarding the Alere's accounting and sales practices. Abbott was able to reach a deal to buy Alere in April for around $5.3 billion, below its initial $5.8 billion offer.
More of What's Trending on TheStreet:
- Dunkin' CEO Reveals Secret Weapon to Win Coffee War With McDonald's: Real Coffee
- My Apple Watch Series 3 Sent the Police to My Apartment: An Unapologetic Review
- They Think it's All Over? Bain-Apple Pays $18 Billion for Toshiba Chip Unit
- Trump Tax Plan Cuts Corporate Rate, Raises Lowest Rate, Leaves Lots Out